Rethinking the classification of alopecia areata

J Am Acad Dermatol. 2019 Feb;80(2):e45. doi: 10.1016/j.jaad.2018.08.059. Epub 2018 Sep 20.

Authors

Carlos G Wambier¹, Brett A King²

Affiliations

¹ Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut; Department of Medicine, State University of Ponta Grossa, Ponta Grossa, Brazil.
² Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut. Electronic address: brett.king@yale.edu.

PMID: 30244065
DOI: 10.1016/j.jaad.2018.08.059

No abstract available

Publication types

Letter

MeSH terms

Alopecia Areata / classification*
Alopecia Areata / drug therapy*
Alopecia Areata / pathology
Clinical Trials as Topic
Female
Humans
Janus Kinase Inhibitors / therapeutic use*
Male
Prognosis
Severity of Illness Index
Thinking*
Treatment Outcome
World Health Organization

Substances

Janus Kinase Inhibitors